Published in PLoS One on December 20, 2012
Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci (2014) 2.37
Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol (2013) 1.31
SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging Cell (2014) 0.94
Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11. Br J Pharmacol (2014) 0.94
Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb Perspect Biol (2013) 0.94
The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression. Eur Heart J (2014) 0.91
Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol (2014) 0.87
Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol (2016) 0.86
Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY) (2014) 0.85
Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Ann Clin Transl Neurol (2014) 0.81
Potential Modulation of Sirtuins by Oxidative Stress. Oxid Med Cell Longev (2015) 0.81
Emerging aspects of treatment in mitochondrial disorders. J Inherit Metab Dis (2015) 0.79
In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions. Biomed Res Int (2016) 0.76
Spectral improvement by fourier thresholding of in vivo dynamic spectroscopy data. Magn Reson Med (2015) 0.75
SIRT1: A Novel Target for the Treatment of Muscular Dystrophies. Oxid Med Cell Longev (2016) 0.75
Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov (2016) 0.75
Sirtuins and nonalcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
Unfolding the pathogenesis of scleroderma through genomics and epigenomics. J Autoimmun (2017) 0.75
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature (2004) 10.32
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature (2007) 10.21
Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol (2010) 8.55
Java-based graphical user interface for the MRUI quantitation package. MAGMA (2001) 5.78
Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol (2005) 5.54
Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab (2008) 5.44
SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell (2007) 5.01
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem (2008) 4.16
Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc (2000) 3.49
Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia (1996) 2.53
Prediction of lean body mass from height and weight. J Clin Pathol (1966) 2.27
SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem (2010) 2.20
Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology (1999) 1.96
Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell (2006) 1.93
Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q (1994) 1.84
SRT1720 improves survival and healthspan of obese mice. Sci Rep (2011) 1.81
Magnetic resonance imaging of total body fat. J Appl Physiol (1985) (1998) 1.76
Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia (2007) 1.67
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov (2007) 1.63
The relationship between aerobic fitness and recovery from high intensity intermittent exercise. Sports Med (2001) 1.56
Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev (2010) 1.39
SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen (2006) 1.36
31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed (2000) 1.30
Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am J Physiol Endocrinol Metab (2008) 1.29
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol (2013) 1.24
A comparison of voluntary and electrically induced contractions by interleaved 1H- and 31P-NMRS in humans. J Appl Physiol (1985) (2002) 1.22
Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2010) 1.21
Sirt1: a metabolic master switch that modulates lifespan. Nat Med (2006) 1.20
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun (2008) 1.16
Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT. J Clin Pharmacol (2007) 1.10
Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr (2003) 1.02
Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care (2004) 1.01
Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle. Am J Physiol Regul Integr Comp Physiol (2011) 1.00
In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology (1991) 0.97
The role of SirT1 in muscle mitochondrial turnover. Mitochondrion (2011) 0.96
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators. Bioorg Med Chem Lett (2008) 0.96
Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism. Muscle Nerve (2001) 0.93
Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta (2010) 0.89
Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest (1995) 0.86
Reduced muscle oxidative capacity is independent of O2 availability in elderly people. Age (Dordr) (2012) 0.86
Niacin: vitamin and antidyslipidemic drug. Subcell Biochem (2012) 0.81
Pragmatic study of orlistat 60 mg on abdominal obesity. Eur J Clin Nutr (2011) 0.79
High-energy phosphate metabolism during incremental calf exercise in humans measured by 31 phosphorus magnetic resonance spectroscopy (31P MRS). Magn Reson Imaging (2004) 0.78
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med (2013) 5.22
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet (2003) 3.57
Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science (2013) 3.40
The role of ipsilateral premotor cortex in hand movement after stroke. Proc Natl Acad Sci U S A (2002) 3.27
Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci (2009) 3.25
Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol (2008) 2.85
Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation (2010) 2.85
Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain (2007) 2.80
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain (2002) 2.57
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation (2012) 2.54
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab (2011) 2.52
Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci (2003) 2.44
Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol (2011) 2.39
Cognitive motor interference while walking: a systematic review and meta-analysis. Neurosci Biobehav Rev (2010) 2.33
White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol (2005) 2.29
Neuroscience thinks big (and collaboratively). Nat Rev Neurosci (2013) 2.21
Thalamic neurodegeneration in multiple sclerosis. Ann Neurol (2002) 2.20
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation (2008) 2.18
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 2.17
DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage (2010) 2.10
Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci (2002) 2.10
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med (2010) 2.00
Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg (2004) 1.93
MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med (2009) 1.93
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab (2010) 1.85
The role of the posterior fusiform gyrus in reading. J Cogn Neurosci (2006) 1.85
Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res (2005) 1.84
Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol (2005) 1.83
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
SRT1720 improves survival and healthspan of obese mice. Sci Rep (2011) 1.81
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol (2009) 1.76
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations. J Neurosci (2007) 1.76
New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry (2004) 1.75
SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem (2010) 1.75
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage (2010) 1.66
Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry (2007) 1.66
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology (2012) 1.63
Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage (2008) 1.62
Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation (2005) 1.62
APJ acts as a dual receptor in cardiac hypertrophy. Nature (2012) 1.62
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humans. Cereb Cortex (2005) 1.61
Variability in fMRI: a re-examination of inter-session differences. Hum Brain Mapp (2005) 1.59
Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation (2003) 1.57
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med (2005) 1.56
Morphology and the internal structure of words. Proc Natl Acad Sci U S A (2004) 1.52
MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage (2009) 1.48
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol (2011) 1.48
Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin Sci (Lond) (2002) 1.46
Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res (2003) 1.46
Functional anatomy of interhemispheric cortical connections in the human brain. J Anat (2006) 1.45
Independent anatomical and functional measures of the V1/V2 boundary in human visual cortex. J Vis (2005) 1.44
Radiation effects in the rat spinal cord: evaluation with apparent diffusion coefficient versus T2 at serial MR imaging. Radiology (2008) 1.44
Hemispheric specialization for processing auditory nonspeech stimuli. Cereb Cortex (2005) 1.44
Avoidance of aluminum toxicity in freshwater snails involves intracellular silicon-aluminum biointeraction. Environ Sci Technol (2008) 1.43
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer (2007) 1.42
Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry (2004) 1.42
The Selective Sirtuin 1 Activator SRT2104 Reduces Endotoxin-Induced Cytokine Release and Coagulation Activation in Humans. Crit Care Med (2015) 1.41
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. Cochrane Database Syst Rev (2016) 1.39
Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation (2008) 1.39
Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage (2007) 1.37
Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke (2006) 1.37
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials (2006) 1.35
Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med (2006) 1.35
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr Res (2006) 1.30
Brain activity changes associated with treadmill training after stroke. Stroke (2009) 1.29
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. Br J Clin Pharmacol (2005) 1.29
Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain (2005) 1.28
Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design. Neuroimage (2005) 1.28
Perceiving identical sounds as speech or non-speech modulates activity in the left posterior superior temporal sulcus. Neuroimage (2005) 1.28
Structural and functional bases for individual differences in motor learning. Hum Brain Mapp (2011) 1.27
Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage (2009) 1.26
Biexponential parameterization of diffusion and T2 relaxation decay curves in a rat muscle edema model: decay curve components and water compartments. Magn Reson Med (2005) 1.26
Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage (2010) 1.25
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol (2013) 1.24
Two-dimensional population map of cortical connections in the human internal capsule. J Magn Reson Imaging (2007) 1.24
SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLoS One (2012) 1.23
Proton T2 relaxation time of J-coupled cerebral metabolites in rat brain at 9.4 T. NMR Biomed (2008) 1.23
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost (2008) 1.22
Testing for dual brain processing routes in reading: a direct contrast of chinese character and pinyin reading using FMRI. J Cogn Neurosci (2002) 1.21
Patient expectations in placebo-controlled randomized clinical trials. J Eval Clin Pract (2005) 1.19
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain (2006) 1.18